Trade Summary

3 days ago, Bizily Scott, serving as Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 9,810 shares at $12.00 per share, for a total transaction value of $117,720.00. Following this transaction, Bizily Scott now holds 8,617 shares of FDMT.

This sale represents a 53.24% decrease in Bizily Scott's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 at 4:38 PM ET, 2 days after the trade was made.

4D Molecular Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.